Table 1 Distribution of the study participants by age, gender, height, disease duration and other clinical characteristics
Experimental-group | Control-group | |||
|---|---|---|---|---|
Subjects (M/F) | 10 (6/4) | 10 (5/5) | ||
Height (m) | 1.59 ±0.10 | 1.60 ±0.12 | ||
Age (years) | 70.27 ±9.81 | 68.42 ± 9.41 | ||
Disease duration (years) | 8.41 ±4.99 | 8.72 ±4.74 | ||
Hoehn & Yahr stage (range) | 2.5 – 3.5 | 2.5 - 3.5 | ||
T0 session | T1 session | T0 session | T1 session | |
UPDRS III score | 53.57 ±14.74 | 40.45 ± 7.88 p = 0.0027 | 56.17 ±13.86 | 40.25 ±8.21 p = 0.0055 |